13.150
−0,38%
2026-10-16
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +15.5% | +158.3% | 2 / 3 | -6.4% | +0.89 pp | +0.86 pp | +10.1% | 1.59 | 10.20 | 228 | −6,4% | 9,8 | +17,0% | 10.20 | 12.74 | −19,9% |
| Pts | 0 | 12 | 8 | 0 | 8 | 8 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 13.150 (close price on 2026-10-16)EPS (TTM): 1.289
Financial charts
1.Revenue & growth
VND bn228Q2/26
1.Revenue & growth
VND bn228Q2/26
2.Profit & growth
VND bn9,54Q2/26
3.Profit mix (Penman)
VND bn43,0Q2/26
4.Margins & cost structure
%38.5%Q2/26
5.Returns & cash cycle
% · days4.1%Q2/26
6.Earnings quality & cash
VND bn150Q2/26
7.Asset structure
VND bn882Q2/26
8.Funding & debt health
VND bn · times882Q2/26
9.Revenue backlog
VND bn2,46Q2/26
10.Valuation
times · %10,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %434Q2/26
Adjusted EPS growth, latest quarter
15.5%
Average adjusted EPS growth, 3 quarters
158%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26